Ind-Swift Laboratories Limited (INDSWFTLAB) reports a 50% revenue increase and a 5.2x surge in Op. EBITDA for Q2 FY27.
Lyka Labs Limited (LYKALABS) reports a 34% revenue surge and a 136% net profit increase in Q2FY27.
Max Healthcare Institute Limited (MAXHEALTH) reports Q2 FY27 revenue of ₹3,219 Cr, up 20% YoY, with PAT rising 10% to ₹448 Cr.
OneSource Specialty Pharma Limited (NSE: ONESOURCE) receives USFDA EIR with VAI classification for its Bengaluru facility, marking successful completion of i.
Wanbury Limited (NSE: WANBURY) secures Australian TGA GMP compliance for its Tanuku plant, enhancing its global pharmaceutical manufacturing credentials.
Hikal Limited (NSE: HIKAL) announces Swissmedic GMP certification for Bengaluru API facility, enhancing global market access.
Sun Pharma's ILUMYA® gains FDA approval for treating psoriatic arthritis, expanding its therapeutic portfolio and benefits for patients.
Indegene Limited (INDGN) reports strong Q2 FY27 performance with 39.5% YoY revenue growth and H1 USD revenue hitting a four-year high.
Alivus Life Sciences Limited (NSE: ALIVUS) announced Q2FY27 results with 16.0% YoY revenue growth, EBITDA margin at 41.8%, and strong cash flow.
Sanofi India Limited's board meeting concluded at 4:45 p.m. on October 29, 2026, with significant focus on strategic initiatives.